vTv Therapeutics News - VTVT

Company Name	Stock Ticker Symbol	Market	Type
vTv Therapeutics Inc	VTVT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	25.50	09:00:20

Open Price	Low Price	High Price	Close Price	Prev Close
				25.50

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/19/2024	08:30	PRNUS	CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
3/13/2024	08:00	GLOBE	vTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
3/07/2024	16:47	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
3/05/2024	19:52	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
3/05/2024	08:04	EDGAR2	Form 8-K - Current report
3/04/2024	08:00	GLOBE	vTv Therapeutics Announces FDA Submission for First Phase 3..
3/01/2024	08:00	GLOBE	vTv Therapeutics to Participate at the TD Cowen 44th Annual..
2/28/2024	09:26	EDGAR2	Form 8-K - Current report
2/28/2024	09:14	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/28/2024	08:08	EDGAR2	Form 8-K - Current report
2/28/2024	08:00	GLOBE	vTv Therapeutics Announces $51 Million Private Placement..
2/22/2024	16:00	PRNUS	CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
12/22/2023	16:26	EDGAR2	Form 8-K - Current report
12/19/2023	16:28	EDGAR2	Form 8-K - Current report
12/12/2023	16:21	EDGAR2	Form 8-K - Current report
11/20/2023	16:23	EDGAR2	Form 8-K - Current report
11/15/2023	08:22	EDGAR2	Form 8-K - Current report
11/15/2023	08:19	EDGAR2	Form 8-K - Current report
11/09/2023	16:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:30	GLOBE	vTv Therapeutics Announces 2023 Third Quarter Financial..
11/09/2023	16:20	EDGAR2	Form 8-K - Current report
11/08/2023	08:00	GLOBE	vTv Therapeutics to Participate at the Stifel 2023..
11/02/2023	08:00	GLOBE	vTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
11/01/2023	08:24	EDGAR2	Form 8-K - Current report
11/01/2023	08:00	GLOBE	vTv Therapeutics Announces Sale of Shares in Reneo..
9/27/2023	08:30	PRNUS	CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
9/26/2023	08:30	PRNUS	Cantex and Allegheny Health Network Announce Initiation of a..
9/25/2023	16:20	EDGAR2	Form DEF 14C - Other definitive information statements
9/18/2023	08:30	PRNUS	CANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
9/15/2023	16:17	EDGAR2	Form PRE 14C - Other preliminary information statements
8/11/2023	16:40	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	16:36	EDGAR2	Form 8-K - Current report
8/11/2023	16:30	GLOBE	vTv Therapeutics Announces 2023 Second Quarter Financial..
8/10/2023	08:33	PRNUS	Cantex Pharmaceuticals Announces Article Published in npj..
7/20/2023	16:22	EDGAR2	Form 8-K - Current report
6/16/2023	08:00	GLOBE	vTv Therapeutics Partner Cantex Pharmaceuticals Licenses..
6/15/2023	07:33	PRNUS	CANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY..
5/24/2023	09:00	GLOBE	vTv Therapeutics Announces Issuance of U.S. Patent for..
5/11/2023	16:15	GLOBE	vTv Therapeutics Announces 2023 First Quarter Financial..